Achilles Therapeutics Stock Forecast - Accumulation Distribution

ACHLDelisted Stock  USD 1.48  0.00  0.00%   
Achilles Stock outlook is based on your current time horizon.
The value of RSI of Achilles Therapeutics' share price is above 70 as of now. This suggests that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Achilles, making its price go up or down.

Momentum 75

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of Achilles Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Achilles Therapeutics and does not consider all of the tangible or intangible factors available from Achilles Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Achilles Therapeutics PLC, which may create opportunities for some arbitrage if properly timed.
Using Achilles Therapeutics hype-based prediction, you can estimate the value of Achilles Therapeutics PLC from the perspective of Achilles Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.

Achilles Therapeutics after-hype prediction price

    
  USD 1.48  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Achilles Therapeutics Additional Predictive Modules

Most predictive techniques to examine Achilles price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Achilles using various technical indicators. When you analyze Achilles charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Achilles Therapeutics PLC has current Accumulation Distribution of 0.0333. The accumulation distribution (A/D) indicator shows the degree to which Achilles Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Achilles Therapeutics PLC to determine if accumulation or reduction is taking place in the market. This value is adjusted by Achilles Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Achilles Therapeutics VolatilityBacktest Achilles TherapeuticsInformation Ratio  

Achilles Therapeutics Trading Date Momentum

On January 28 2026 Achilles Therapeutics PLC was traded for  1.48  at the closing time. The top price for the day was 1.50  and the lowest listed price was  1.45 . There was no trading activity during the period 0.0. Lack of trading volume on January 28, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Achilles Therapeutics to competition

Achilles Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Achilles Therapeutics stock to make a market-neutral strategy. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Achilles Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Achilles Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Achilles Therapeutics shares will generate the highest return on investment. By undertsting and applying Achilles Therapeutics stock market strength indicators, traders can identify Achilles Therapeutics PLC entry and exit signals to maximize returns.

Achilles Therapeutics Risk Indicators

The analysis of Achilles Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Achilles Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting achilles stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Achilles Therapeutics

The number of cover stories for Achilles Therapeutics depends on current market conditions and Achilles Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Achilles Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Achilles Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Achilles Therapeutics Short Properties

Achilles Therapeutics' future price predictability will typically decrease when Achilles Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Achilles Therapeutics PLC often depends not only on the future outlook of the potential Achilles Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Achilles Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding40 M
Cash And Short Term Investments131.5 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Achilles Stock

If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio